Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80 - Université de Lille Accéder directement au contenu
Article Dans Une Revue Journal of Allergy and Clinical Immunology: In Practice Année : 2022

Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80

Résumé

This case of an anaphylactic reaction to nivolumab shows the usefulness of skin tests to look for hypersensitivity to excipients, such as polysorbate 80, to research therapeutic alternatives, and to avoid recurrences of hypersensitivity with other products.

Dates et versions

hal-04225948 , version 1 (03-10-2023)

Identifiants

Citer

Pauline Podevin, Julie Vanlerberghe, Carole Templier, Damien Lannoy, Selma Azib, et al.. Anaphylactic reaction to checkpoint inhibitors with confirmed hypersensitivity to polysorbate 80. Journal of Allergy and Clinical Immunology: In Practice, 2022, Journal of Allergy and Clinical Immunology: In Practice, 11 (2), pp.655-657. ⟨10.1016/j.jaip.2022.12.009⟩. ⟨hal-04225948⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More